Hints and tips:
Related Special Reports
...At clinical psychologist Dr Stephen Blumenthal’s practice in central London, he sees lots of people — many of them very successful in business — who have experienced buyer’s remorse....
...The UK government said the review will recommend a shortlist of “priority actions”, as well as taking a view on longer term ambitions for UK clinical trials....
...Although the NHS had since 2021 opened about 160 community diagnostic centres — one-stop shops for checks and scans — England still had one-fifth of the diagnostic capacity of Australia and less than half...
...The government is also pledging £6mn in funding for UK early-stage biotechs working on diagnostics for neurodegenerative diseases and facilitating clinical trials....
...Specification: Psychopathology Click the link below to read the article and then answer the questions: AI-designed drug to enter human clinical trial for first time Name two other drugs used to treat...
...He’s the clinical director for Cruse Bereavement Support, the largest bereavement charity in the UK....
...In 1994 one of the very first clinical trials for the drug that became Viagra took place in Swansea....
...Still, Delaware, Inc is going to have to decide whether its brand should be based on being an even-handed, dispassionate system or something more corporate-friendly, designed to keep up in a regulatory race...
...The other, diagnostics specialist InHealth Group, has been working with the health service for three decades....
...These ultra-diagnostics are increasingly big business: preventative medicine has officially moved from the biohacking fringes to the moneyed mainstream....
...“[The] approach is practical and can achieve a high level of diagnostic accuracy, even when carried out by local health workers in resource-limited clinical settings,” the Shanghai scientists write in the...
...Interest in deploying AI in a clinical setting has soared with evidence of its contribution to diagnostics, such as flagging early-stage breast cancers that may be missed by doctors....
...The Financial Times reported last week that Pfizer was planning to offer its Covid antiviral Paxlovid, its Covid and flu diagnostic kit Lucira and certain migraine medications on the platform later this...
Being ‘in love’ is subjected to clinical analysis in Christos Nikou’s film
...Lord O’Shaughnessy wants to quadruple the number of NHS patients in clinical trials (“No ‘magic wand’ for financial pressures, Hunt tells pharma groups”, Report, May 26)....
...More diagnostic equipment is badly needed in the NHS, which has fewer scanners and other facilities than many comparable OECD countries....
...It already made its diagnostics products in the country but had “limited manufacturing for pharma”, he added....
...Genomics England has a follow-up programme, Cancer 2.0, which aims to extend the diagnostic potential of whole genome sequencing....
...referred to in the essay albeit not by name, Samuel P Huntington wrote that “if civilisation is what counts . . . violence between Ukrainians and Russians is unlikely”, being two Slavic, primarily Orthodox...
...Vertex hopes to receive US Food and Drug Administration approval for a non-opioid painkiller, known as VX-548, this year after a late-stage clinical study showed it lowered pain with a far lower incidence...
...The emergence of potential dementia diagnostics follows progress towards possible treatments....
...Some NHS staff need to “get over cultural sniffiness” about profit motives to work with pharmaceutical and tech companies to reverse the steep drop in UK clinical trials, shadow health secretary Wes Streeting...
...It has long been said that this is the reason why Japan Inc is an export-oriented country. Leo Lewis reported, “Japan Inc returns to overseas deals trail as domestic arena shrinks” (Report, July 14)....
...J&J’s medtech division has outstripped the growth of the company’s drugs and diagnostics business, generating $30.4bn in sales last year, or 35 per cent of group revenues....
...Almost two dozen clinical trials on drugs seeking to treat Alzheimer’s by reducing these plaques have failed since 2003, prompting scepticism among some experts that removing amyloid can slow progression...
International Edition